Skip to content
WealthTicker

Compare

NAVs as of 20 Aug 2026

Mirae Asset Banking and Financial Services FundRegular · IDCW1 of 4 funds

Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (248 funds), which is the only comparison one fund can support.

Growth of ₹100 (rebased over the selected window)

Common period 14 Dec 202020 Aug 2026, limited by Mirae Asset Banking and Financial Services Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.

View as table
Growth of ₹100, sampled across the common period
DateMirae Asset Banking and Financial Services FundNifty Bank
14 Dec 2020₹100.00₹100.00
05 Jun 2021₹117.11₹114.78
25 Nov 2021₹126.65₹121.53
17 May 2022₹111.35₹111.57
06 Nov 2022₹131.80₹134.19
28 Apr 2023₹135.68₹140.62
18 Oct 2023₹153.18₹142.75
07 Apr 2024₹169.26₹157.72
27 Sep 2024₹195.51₹175.09
19 Mar 2025₹181.45₹161.66
08 Sep 2025₹200.20₹176.24
28 Feb 2026₹221.40₹196.87
20 Aug 2026₹215.79₹187.00
Mirae Asset Banking and Financial Services Fund compared on return, risk, benchmark-relative, cost and portfolio metrics, against the Sectoral/ Thematic median.
Metric
Mirae Asset · Regular · IDCW
NAV ₹21.64
Very High risk
★★★★☆
Category median
Sectoral/ Thematic · 248 funds
+5.67%+3.54%
+13.05%+11.47%
+12.74%+9.70%
+10.32%
+14.50%+9.15%
+12.74%
+16.08%+12.10%
+14.03%+10.32%
+8.80%
Risk
15.67%15.91%
0.420.25
0.580.32
-21.76%-26.14%
Nifty Bank
+3.14%-0.04%
0.900.98
100.7%98.3%
83.6%101.5%
2.12%2.38%
₹2,186Cr₹1,160Cr
1.00%
None
₹99
₹5.00K
7%42%
Abhijith Vara
14 Dec 2020
32
66.3%
2.5%

Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.